Moderna (MRNA) IV into COVID-19 vaccine boosters get FDA authorization
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) 30-day option implied volatility is at 60; compared to its 52-week range of 51 to 131 into MRNA & Johnson & Johnson (JNJ) COVID-19 vaccine boosters get FDA authorization.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
- Booking Holdings (BKNG) call put ratio 1 call to 2.1 puts into quarter results
- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, FDA, jnjSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
